Dasatinib intermediate-1
Dasatinib intermediate-1 is an intermediate in the synthesis of Dasatinib. Dasatinib Is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity[1].
Product Specifications
CAS Number
302964-08-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bcr-Abl
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Purity
98.0
Smiles
O=C(C1=CN=C(NC2=NC(C)=NC(Cl)=C2)S1)NC3=C(C)C=CC=C3Cl
Molecular Formula
C16H13Cl2N5OS
Molecular Weight
394.28
Precautions
H302, H315, H319, H335
References & Citations
[1]Distler JH, et al. Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis. Rheumatology (Oxford) . 2008 Oct;47 Suppl 5:v10-1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
420826-01 25 mg
2,6-Difluoro-3- (2'-fluorobenzyloxy) phenylboronic acid
Sign In for Pricing
View Details